Delivery Order SPE2DB20D3103-SPE2DB23FP6W9

Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $5.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4563169008 - NORDITROPIN FLEXPRO 30 MG/3 ML 3ML. The contract, valued at $2,314.16, is a firm fixed-price delivery order with a completion date of December 26, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin Flexpro 30 mg/3 ml 3 ml. The award, a delivery order under contract SPE2DB22FH3V2, has a ceiling value of $10,275.09. The contract is a firm fixed-price agreement with a completion date of January 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Norditropin FlexPro 30 mg/3 mL medication. The contract, valued at $1,133.06, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 15, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,979.04, is for the delivery of Norditropin FlexPro 10 mg/1.5 1.5 ml, a specialty pharmaceutical product. The contract has an ultimate completion date of December 18, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,169.04 firm-fixed-price delivery order is for the supply of 4562802779 - NORDITROPIN FLEXPRO 30 MG/3 ML 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 14, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Norditropin FlexPro 10 mg/1.5 ml, a pharmaceutical product, at a ceiling value of $2,095.29. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $19,604.93, is for the delivery of Norditropin FlexPro 30 mg/3 mL 3 mL syringes. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,169.04, is for the delivery of Norditropin FlexPro 30 mg/3 ml injectable medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Norditropin FlexPro 10 mg/1.5 ml, a prescription medication, with a ceiling value of $1,581.81 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is with the Defense Logistics Agency (DLA) Medical Supply Chain for the pharmaceutical product Norditropin FlexPro 5 mg/1.5 ml. The contract has a total ceiling value of $1,550.41 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP6W9
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Norditropin FlexPro 30 mg/3 ml, a specialty pharmaceutical product. The contract has a ceiling value of $5,941.72 and a completion date of September 12, 2023.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is a delivery order issued under that IDC. No set-aside designation was used for this contract.

Generated 2/27/25, 11:41 AM